Uploaded August 2025 | Updated September 2026, 2 weeks ago
NEW CannMed Coffee Talk, we discuss Recruitment Challenges for Cannabis Clinical Trials!
Dr. Emily Lindley is Assistant Professor of Orthopedics and Director of the Colorado Cannabis Research Consortium. Her team’s research aims to identify non-opioid alternatives for the treatment of chronic musculoskeletal pain. One such alternative that has gained increased recognition in recent years is medical cannabis, and her lab is currently studying the health effects of cannabis and cannabinoids for chronic musculoskeletal pain.
Dr. Rachael Rzasa Lynn is a board certified in pain medicine physician and is an Associate Professor in the Department of Anesthesiology at the University of Colorado, where she is the Associate Program Director for the Pain Medicine Fellowship. Her research includes investigations in opioid pharmacology and the use of cannabis for chronic pain.
Emily and Rachael co-authored a poster presented at the most recent ICRS conference titled, “Recruitment Challenges in Clinical Studies of Cannabis” #shorts #cannabisresearch #cannabiseducation
Watch Now: youtu.be/TV5x6dQ6AMs
During our conversation, we discussed:
⦿ How recruitment for cannabis clinical trials differs from traditional clinical trials
⦿ Why prior experience with cannabis is considered a negative for patient recruitment
⦿ How legal concerns and stigma can deter cannabis-naive patients from enrolling
⦿ Why the participant drop out rate is higher in cannabis trials
⦿ How rescheduling may affect patient recruitment future trials
Thanks to This Episode’s Sponsor: The Society of Cannabis Clinicians
The Society of Cannabis Clinicians’ Med Cann conference offers a rare opportunity for clinicians to dive deep into the clinical realities and therapeutic potential of medical cannabis and psychedelics. Designed with healthcare providers in mind, their sessions focus on case-based learning, emerging protocols, and real-world challenges—offering practical insights that can be immediately applied in your practice.
Learn more at cannabisclinicians.org and use code “CP15” to receive 15% Off Your Registration
NEW CannMed Coffee Talk, we discuss Recruitment Challenges for Cannabis Clinical Trials!
Dr. Emily Lindley is Assistant Professor of Orthopedics and Director of the Colorado Cannabis Research Consortium. Her team’s research aims to identify non-opioid alternatives for the treatment of chronic musculoskeletal pain. One such alternative that has gained increased recognition in recent years is medical cannabis, and her lab is currently studying the health effects of cannabis and cannabinoids for chronic musculoskeletal pain.
Dr. Rachael Rzasa Lynn is a board certified in pain medicine physician and is an Associate Professor in the Department of Anesthesiology at the University of Colorado, where she is the Associate Program Director for the Pain Medicine Fellowship. Her research includes investigations in opioid pharmacology and the use of cannabis for chronic pain.
Emily and Rachael co-authored a poster presented at the most recent ICRS conference titled, “Recruitment Challenges in Clinical Studies of Cannabis” #shorts #cannabisresearch #cannabiseducation
Watch Now: youtu.be/TV5x6dQ6AMs
During our conversation, we discussed:
⦿ How recruitment for cannabis clinical trials differs from traditional clinical trials
⦿ Why prior experience with cannabis is considered a negative for patient recruitment
⦿ How legal concerns and stigma can deter cannabis-naive patients from enrolling
⦿ Why the participant drop out rate is higher in cannabis trials
⦿ How rescheduling may affect patient recruitment future trials
Thanks to This Episode’s Sponsor: The Society of Cannabis Clinicians
The Society of Cannabis Clinicians’ Med Cann conference offers a rare opportunity for clinicians to dive deep into the clinical realities and therapeutic potential of medical cannabis and psychedelics. Designed with healthcare providers in mind, their sessions focus on case-based learning, emerging protocols, and real-world challenges—offering practical insights that can be immediately applied in your practice.
Learn more at cannabisclinicians.org and use code “CP15” to receive 15% Off Your Registration




![What were some peaks/trends in the data that seemed informative in your CHS survey? - Codi Peterson
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ What were some peaks/trends in the data that seemed informative in your CHS survey? - Codi Peterson](https://i.ytimg.com/vi/lFtfCNKV8rE/mqdefault.jpg)





